nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—MPO—prostate cancer	0.227	1	CbGaD
L-Carnitine—SLC22A16—Doxorubicin—prostate cancer	0.143	0.34	CbGbCtD
L-Carnitine—CES1—Capecitabine—prostate cancer	0.0848	0.201	CbGbCtD
L-Carnitine—SLCO1B1—Cabazitaxel—prostate cancer	0.0394	0.0933	CbGbCtD
L-Carnitine—SLCO1B1—Estrone—prostate cancer	0.0385	0.0912	CbGbCtD
L-Carnitine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0252	0.0597	CbGbCtD
L-Carnitine—XDH—Doxorubicin—prostate cancer	0.0247	0.0587	CbGbCtD
L-Carnitine—SLC22A8—Conjugated Estrogens—prostate cancer	0.0232	0.0551	CbGbCtD
L-Carnitine—SLCO1B1—Estradiol—prostate cancer	0.0221	0.0524	CbGbCtD
L-Carnitine—SLC22A8—Estradiol—prostate cancer	0.0204	0.0484	CbGbCtD
L-Carnitine—SLC25A29—prostate gland—prostate cancer	0.00342	0.045	CbGeAlD
L-Carnitine—CROT—prostate gland—prostate cancer	0.00313	0.0413	CbGeAlD
L-Carnitine—SLC22A16—renal system—prostate cancer	0.00295	0.0389	CbGeAlD
L-Carnitine—SLC25A20—prostate gland—prostate cancer	0.00272	0.0359	CbGeAlD
L-Carnitine—CRAT—prostate gland—prostate cancer	0.00264	0.0348	CbGeAlD
L-Carnitine—SLC25A20—seminal vesicle—prostate cancer	0.0023	0.0304	CbGeAlD
L-Carnitine—SLC22A8—urine—prostate cancer	0.00225	0.0296	CbGeAlD
L-Carnitine—CRAT—seminal vesicle—prostate cancer	0.00224	0.0295	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—prostate cancer	0.00223	0.0294	CbGeAlD
L-Carnitine—CPT1A—prostate gland—prostate cancer	0.00214	0.0282	CbGeAlD
L-Carnitine—CPT2—prostate gland—prostate cancer	0.00203	0.0268	CbGeAlD
L-Carnitine—SLC22A16—testis—prostate cancer	0.00191	0.0251	CbGeAlD
L-Carnitine—SLC25A20—renal system—prostate cancer	0.00186	0.0245	CbGeAlD
L-Carnitine—SLC25A20—urethra—prostate cancer	0.00182	0.024	CbGeAlD
L-Carnitine—CRAT—renal system—prostate cancer	0.0018	0.0237	CbGeAlD
L-Carnitine—CRAT—urethra—prostate cancer	0.00177	0.0233	CbGeAlD
L-Carnitine—CPT2—seminal vesicle—prostate cancer	0.00172	0.0227	CbGeAlD
L-Carnitine—CROT—bone marrow—prostate cancer	0.00161	0.0213	CbGeAlD
L-Carnitine—XDH—prostate gland—prostate cancer	0.00158	0.0209	CbGeAlD
L-Carnitine—SLC25A29—testis—prostate cancer	0.0015	0.0198	CbGeAlD
L-Carnitine—CPT1A—renal system—prostate cancer	0.00146	0.0192	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—prostate cancer	0.0014	0.0185	CbGeAlD
L-Carnitine—CPT2—renal system—prostate cancer	0.00139	0.0183	CbGeAlD
L-Carnitine—CROT—testis—prostate cancer	0.00138	0.0182	CbGeAlD
L-Carnitine—CRAT—bone marrow—prostate cancer	0.00136	0.018	CbGeAlD
L-Carnitine—CPT2—urethra—prostate cancer	0.00136	0.0179	CbGeAlD
L-Carnitine—CES1—prostate gland—prostate cancer	0.00121	0.0159	CbGeAlD
L-Carnitine—SLC25A20—testis—prostate cancer	0.0012	0.0158	CbGeAlD
L-Carnitine—CRAT—testis—prostate cancer	0.00116	0.0153	CbGeAlD
L-Carnitine—SLC25A29—lymph node—prostate cancer	0.00109	0.0144	CbGeAlD
L-Carnitine—XDH—renal system—prostate cancer	0.00108	0.0142	CbGeAlD
L-Carnitine—CPT2—bone marrow—prostate cancer	0.00105	0.0138	CbGeAlD
L-Carnitine—CROT—lymph node—prostate cancer	0.001	0.0132	CbGeAlD
L-Carnitine—CPT1A—testis—prostate cancer	0.000944	0.0124	CbGeAlD
L-Carnitine—SLC22A4—prostate gland—prostate cancer	0.000921	0.0121	CbGeAlD
L-Carnitine—CPT2—testis—prostate cancer	0.000896	0.0118	CbGeAlD
L-Carnitine—Choline—PDE4D—prostate cancer	0.000884	0.308	CrCbGaD
L-Carnitine—SLC25A20—lymph node—prostate cancer	0.00087	0.0115	CbGeAlD
L-Carnitine—CRAT—lymph node—prostate cancer	0.000844	0.0111	CbGeAlD
L-Carnitine—SLC22A8—prostate gland—prostate cancer	0.000806	0.0106	CbGeAlD
L-Carnitine—SLC22A4—seminal vesicle—prostate cancer	0.000779	0.0103	CbGeAlD
L-Carnitine—Choline—SLC22A3—prostate cancer	0.000757	0.264	CrCbGaD
L-Carnitine—MPO—epithelium—prostate cancer	0.000741	0.00977	CbGeAlD
L-Carnitine—SLCO1B1—renal system—prostate cancer	0.000707	0.00932	CbGeAlD
L-Carnitine—MPO—renal system—prostate cancer	0.000687	0.00906	CbGeAlD
L-Carnitine—Choline—ACHE—prostate cancer	0.000685	0.239	CrCbGaD
L-Carnitine—CPT1A—lymph node—prostate cancer	0.000684	0.00902	CbGeAlD
L-Carnitine—CPT2—lymph node—prostate cancer	0.000649	0.00856	CbGeAlD
L-Carnitine—SLC22A4—renal system—prostate cancer	0.000628	0.00827	CbGeAlD
L-Carnitine—SLC22A5—prostate gland—prostate cancer	0.000609	0.00803	CbGeAlD
L-Carnitine—SLC22A8—renal system—prostate cancer	0.000549	0.00724	CbGeAlD
L-Carnitine—Choline—SLC22A1—prostate cancer	0.000543	0.189	CrCbGaD
L-Carnitine—CES1—testis—prostate cancer	0.000532	0.00701	CbGeAlD
L-Carnitine—MPO—bone marrow—prostate cancer	0.00052	0.00685	CbGeAlD
L-Carnitine—SLC22A5—seminal vesicle—prostate cancer	0.000515	0.00679	CbGeAlD
L-Carnitine—SLC22A4—bone marrow—prostate cancer	0.000475	0.00625	CbGeAlD
L-Carnitine—MPO—testis—prostate cancer	0.000444	0.00585	CbGeAlD
L-Carnitine—SLC22A5—renal system—prostate cancer	0.000415	0.00547	CbGeAlD
L-Carnitine—SLC22A5—urethra—prostate cancer	0.000408	0.00538	CbGeAlD
L-Carnitine—CES1—lymph node—prostate cancer	0.000386	0.00508	CbGeAlD
L-Carnitine—MPO—lymph node—prostate cancer	0.000322	0.00424	CbGeAlD
L-Carnitine—SLC22A4—lymph node—prostate cancer	0.000294	0.00388	CbGeAlD
L-Carnitine—SLC22A5—testis—prostate cancer	0.000268	0.00354	CbGeAlD
L-Carnitine—SLC22A5—lymph node—prostate cancer	0.000195	0.00256	CbGeAlD
L-Carnitine—Dysgeusia—Capecitabine—prostate cancer	8.42e-05	0.000613	CcSEcCtD
L-Carnitine—Nausea—Conjugated Estrogens—prostate cancer	8.35e-05	0.000608	CcSEcCtD
L-Carnitine—Back pain—Capecitabine—prostate cancer	8.32e-05	0.000606	CcSEcCtD
L-Carnitine—Anorexia—Etoposide—prostate cancer	8.32e-05	0.000605	CcSEcCtD
L-Carnitine—Hypersensitivity—Estradiol—prostate cancer	8.29e-05	0.000604	CcSEcCtD
L-Carnitine—Body temperature increased—Mitoxantrone—prostate cancer	8.29e-05	0.000604	CcSEcCtD
L-Carnitine—Abdominal pain—Mitoxantrone—prostate cancer	8.29e-05	0.000604	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—prostate cancer	8.27e-05	0.000602	CcSEcCtD
L-Carnitine—Muscle spasms—Capecitabine—prostate cancer	8.27e-05	0.000602	CcSEcCtD
L-Carnitine—Eye disorder—Prednisone—prostate cancer	8.22e-05	0.000599	CcSEcCtD
L-Carnitine—Anaemia—Docetaxel—prostate cancer	8.21e-05	0.000598	CcSEcCtD
L-Carnitine—Hypotension—Etoposide—prostate cancer	8.15e-05	0.000593	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—prostate cancer	8.15e-05	0.000593	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—prostate cancer	8.12e-05	0.000591	CcSEcCtD
L-Carnitine—Asthenia—Estradiol—prostate cancer	8.08e-05	0.000588	CcSEcCtD
L-Carnitine—Angiopathy—Prednisone—prostate cancer	7.98e-05	0.000581	CcSEcCtD
L-Carnitine—Pruritus—Estradiol—prostate cancer	7.96e-05	0.00058	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—prostate cancer	7.96e-05	0.000579	CcSEcCtD
L-Carnitine—Anaemia—Capecitabine—prostate cancer	7.95e-05	0.000579	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisone—prostate cancer	7.86e-05	0.000572	CcSEcCtD
L-Carnitine—Palpitations—Docetaxel—prostate cancer	7.85e-05	0.000571	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—prostate cancer	7.83e-05	0.00057	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—prostate cancer	7.83e-05	0.00057	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—prostate cancer	7.78e-05	0.000566	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—prostate cancer	7.78e-05	0.000566	CcSEcCtD
L-Carnitine—Cough—Docetaxel—prostate cancer	7.75e-05	0.000564	CcSEcCtD
L-Carnitine—Vertigo—Capecitabine—prostate cancer	7.73e-05	0.000562	CcSEcCtD
L-Carnitine—Hypersensitivity—Mitoxantrone—prostate cancer	7.73e-05	0.000562	CcSEcCtD
L-Carnitine—Diarrhoea—Estradiol—prostate cancer	7.7e-05	0.000561	CcSEcCtD
L-Carnitine—Convulsion—Docetaxel—prostate cancer	7.7e-05	0.00056	CcSEcCtD
L-Carnitine—Hypertension—Docetaxel—prostate cancer	7.67e-05	0.000558	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—prostate cancer	7.65e-05	0.000557	CcSEcCtD
L-Carnitine—Palpitations—Capecitabine—prostate cancer	7.6e-05	0.000553	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—prostate cancer	7.58e-05	0.000552	CcSEcCtD
L-Carnitine—Chest pain—Docetaxel—prostate cancer	7.56e-05	0.000551	CcSEcCtD
L-Carnitine—Myalgia—Docetaxel—prostate cancer	7.56e-05	0.000551	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—prostate cancer	7.54e-05	0.000549	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—prostate cancer	7.53e-05	0.000548	CcSEcCtD
L-Carnitine—Asthenia—Mitoxantrone—prostate cancer	7.52e-05	0.000548	CcSEcCtD
L-Carnitine—Cough—Capecitabine—prostate cancer	7.5e-05	0.000546	CcSEcCtD
L-Carnitine—Constipation—Etoposide—prostate cancer	7.46e-05	0.000543	CcSEcCtD
L-Carnitine—Pain—Etoposide—prostate cancer	7.46e-05	0.000543	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—prostate cancer	7.45e-05	0.000543	CcSEcCtD
L-Carnitine—Dizziness—Estradiol—prostate cancer	7.44e-05	0.000542	CcSEcCtD
L-Carnitine—Hypertension—Capecitabine—prostate cancer	7.43e-05	0.000541	CcSEcCtD
L-Carnitine—Myalgia—Capecitabine—prostate cancer	7.32e-05	0.000533	CcSEcCtD
L-Carnitine—Chest pain—Capecitabine—prostate cancer	7.32e-05	0.000533	CcSEcCtD
L-Carnitine—Anxiety—Capecitabine—prostate cancer	7.3e-05	0.000531	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—prostate cancer	7.24e-05	0.000527	CcSEcCtD
L-Carnitine—Infection—Docetaxel—prostate cancer	7.2e-05	0.000524	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—prostate cancer	7.2e-05	0.000524	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—prostate cancer	7.19e-05	0.000524	CcSEcCtD
L-Carnitine—Diarrhoea—Mitoxantrone—prostate cancer	7.18e-05	0.000522	CcSEcCtD
L-Carnitine—Vomiting—Estradiol—prostate cancer	7.16e-05	0.000521	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—prostate cancer	7.13e-05	0.000519	CcSEcCtD
L-Carnitine—Rash—Estradiol—prostate cancer	7.1e-05	0.000517	CcSEcCtD
L-Carnitine—Dermatitis—Estradiol—prostate cancer	7.09e-05	0.000516	CcSEcCtD
L-Carnitine—Anaemia—Prednisone—prostate cancer	7.08e-05	0.000515	CcSEcCtD
L-Carnitine—Tachycardia—Docetaxel—prostate cancer	7.08e-05	0.000515	CcSEcCtD
L-Carnitine—Headache—Estradiol—prostate cancer	7.05e-05	0.000513	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—prostate cancer	6.97e-05	0.000508	CcSEcCtD
L-Carnitine—Infection—Capecitabine—prostate cancer	6.97e-05	0.000508	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—prostate cancer	6.92e-05	0.000504	CcSEcCtD
L-Carnitine—Anorexia—Docetaxel—prostate cancer	6.91e-05	0.000503	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—prostate cancer	6.9e-05	0.000502	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—prostate cancer	6.9e-05	0.000502	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—prostate cancer	6.9e-05	0.000502	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—prostate cancer	6.9e-05	0.000502	CcSEcCtD
L-Carnitine—Vertigo—Prednisone—prostate cancer	6.88e-05	0.000501	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—prostate cancer	6.88e-05	0.000501	CcSEcCtD
L-Carnitine—Tachycardia—Capecitabine—prostate cancer	6.85e-05	0.000499	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—prostate cancer	6.83e-05	0.000497	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—prostate cancer	6.78e-05	0.000494	CcSEcCtD
L-Carnitine—Hypotension—Docetaxel—prostate cancer	6.77e-05	0.000493	CcSEcCtD
L-Carnitine—Anorexia—Capecitabine—prostate cancer	6.69e-05	0.000487	CcSEcCtD
L-Carnitine—Nausea—Estradiol—prostate cancer	6.69e-05	0.000487	CcSEcCtD
L-Carnitine—Vomiting—Mitoxantrone—prostate cancer	6.67e-05	0.000485	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—prostate cancer	6.66e-05	0.000485	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—prostate cancer	6.64e-05	0.000483	CcSEcCtD
L-Carnitine—Hypertension—Prednisone—prostate cancer	6.61e-05	0.000481	CcSEcCtD
L-Carnitine—Rash—Mitoxantrone—prostate cancer	6.61e-05	0.000481	CcSEcCtD
L-Carnitine—Dermatitis—Mitoxantrone—prostate cancer	6.61e-05	0.000481	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.6e-05	0.000481	CcSEcCtD
L-Carnitine—Headache—Mitoxantrone—prostate cancer	6.57e-05	0.000478	CcSEcCtD
L-Carnitine—Hypotension—Capecitabine—prostate cancer	6.56e-05	0.000477	CcSEcCtD
L-Carnitine—Insomnia—Docetaxel—prostate cancer	6.56e-05	0.000477	CcSEcCtD
L-Carnitine—Myalgia—Prednisone—prostate cancer	6.52e-05	0.000475	CcSEcCtD
L-Carnitine—Paraesthesia—Docetaxel—prostate cancer	6.51e-05	0.000474	CcSEcCtD
L-Carnitine—Anxiety—Prednisone—prostate cancer	6.5e-05	0.000473	CcSEcCtD
L-Carnitine—Dyspnoea—Docetaxel—prostate cancer	6.46e-05	0.000471	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—prostate cancer	6.43e-05	0.000468	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—prostate cancer	6.43e-05	0.000468	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—prostate cancer	6.4e-05	0.000466	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.39e-05	0.000466	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—prostate cancer	6.38e-05	0.000465	CcSEcCtD
L-Carnitine—Dyspepsia—Docetaxel—prostate cancer	6.38e-05	0.000465	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—prostate cancer	6.37e-05	0.000464	CcSEcCtD
L-Carnitine—Insomnia—Capecitabine—prostate cancer	6.35e-05	0.000462	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—prostate cancer	6.32e-05	0.00046	CcSEcCtD
L-Carnitine—Paraesthesia—Capecitabine—prostate cancer	6.3e-05	0.000459	CcSEcCtD
L-Carnitine—Decreased appetite—Docetaxel—prostate cancer	6.3e-05	0.000459	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—prostate cancer	6.27e-05	0.000457	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Docetaxel—prostate cancer	6.26e-05	0.000456	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—prostate cancer	6.26e-05	0.000456	CcSEcCtD
L-Carnitine—Dyspnoea—Capecitabine—prostate cancer	6.26e-05	0.000456	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—prostate cancer	6.24e-05	0.000455	CcSEcCtD
L-Carnitine—Nausea—Mitoxantrone—prostate cancer	6.23e-05	0.000453	CcSEcCtD
L-Carnitine—Infection—Prednisone—prostate cancer	6.21e-05	0.000452	CcSEcCtD
L-Carnitine—Pain—Docetaxel—prostate cancer	6.2e-05	0.000451	CcSEcCtD
L-Carnitine—Constipation—Docetaxel—prostate cancer	6.2e-05	0.000451	CcSEcCtD
L-Carnitine—Dyspepsia—Capecitabine—prostate cancer	6.18e-05	0.00045	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—prostate cancer	6.17e-05	0.000449	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—prostate cancer	6.15e-05	0.000448	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—prostate cancer	6.1e-05	0.000444	CcSEcCtD
L-Carnitine—Decreased appetite—Capecitabine—prostate cancer	6.1e-05	0.000444	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Capecitabine—prostate cancer	6.06e-05	0.000441	CcSEcCtD
L-Carnitine—Constipation—Capecitabine—prostate cancer	6e-05	0.000437	CcSEcCtD
L-Carnitine—Pain—Capecitabine—prostate cancer	6e-05	0.000437	CcSEcCtD
L-Carnitine—Diarrhoea—Etoposide—prostate cancer	5.97e-05	0.000434	CcSEcCtD
L-Carnitine—Anorexia—Prednisone—prostate cancer	5.96e-05	0.000434	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—prostate cancer	5.95e-05	0.000433	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Docetaxel—prostate cancer	5.93e-05	0.000432	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—prostate cancer	5.87e-05	0.000427	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—prostate cancer	5.8e-05	0.000422	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—prostate cancer	5.78e-05	0.000421	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—prostate cancer	5.77e-05	0.00042	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—prostate cancer	5.76e-05	0.000419	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Capecitabine—prostate cancer	5.74e-05	0.000418	CcSEcCtD
L-Carnitine—Body temperature increased—Docetaxel—prostate cancer	5.73e-05	0.000417	CcSEcCtD
L-Carnitine—Abdominal pain—Docetaxel—prostate cancer	5.73e-05	0.000417	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Prednisone—prostate cancer	5.7e-05	0.000415	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—prostate cancer	5.69e-05	0.000414	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—prostate cancer	5.65e-05	0.000412	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisone—prostate cancer	5.61e-05	0.000409	CcSEcCtD
L-Carnitine—Abdominal pain—Capecitabine—prostate cancer	5.55e-05	0.000404	CcSEcCtD
L-Carnitine—Body temperature increased—Capecitabine—prostate cancer	5.55e-05	0.000404	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—prostate cancer	5.55e-05	0.000404	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—prostate cancer	5.54e-05	0.000403	CcSEcCtD
L-Carnitine—Dyspepsia—Prednisone—prostate cancer	5.5e-05	0.000401	CcSEcCtD
L-Carnitine—Rash—Etoposide—prostate cancer	5.5e-05	0.0004	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—prostate cancer	5.5e-05	0.0004	CcSEcCtD
L-Carnitine—Headache—Etoposide—prostate cancer	5.46e-05	0.000398	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—prostate cancer	5.43e-05	0.000396	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—prostate cancer	5.43e-05	0.000395	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—prostate cancer	5.38e-05	0.000392	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—prostate cancer	5.36e-05	0.00039	CcSEcCtD
L-Carnitine—Constipation—Prednisone—prostate cancer	5.35e-05	0.000389	CcSEcCtD
L-Carnitine—Hypersensitivity—Docetaxel—prostate cancer	5.34e-05	0.000389	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—prostate cancer	5.33e-05	0.000388	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—prostate cancer	5.29e-05	0.000385	CcSEcCtD
L-Carnitine—Cough—Epirubicin—prostate cancer	5.23e-05	0.000381	CcSEcCtD
L-Carnitine—Asthenia—Docetaxel—prostate cancer	5.2e-05	0.000379	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—prostate cancer	5.19e-05	0.000378	CcSEcCtD
L-Carnitine—Nausea—Etoposide—prostate cancer	5.18e-05	0.000377	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—prostate cancer	5.17e-05	0.000377	CcSEcCtD
L-Carnitine—Hypersensitivity—Capecitabine—prostate cancer	5.17e-05	0.000376	CcSEcCtD
L-Carnitine—Pruritus—Docetaxel—prostate cancer	5.13e-05	0.000373	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—prostate cancer	5.12e-05	0.000373	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Prednisone—prostate cancer	5.11e-05	0.000372	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—prostate cancer	5.1e-05	0.000371	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—prostate cancer	5.1e-05	0.000371	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—prostate cancer	5.08e-05	0.00037	CcSEcCtD
L-Carnitine—Asthenia—Capecitabine—prostate cancer	5.04e-05	0.000367	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—prostate cancer	4.98e-05	0.000363	CcSEcCtD
L-Carnitine—Pruritus—Capecitabine—prostate cancer	4.97e-05	0.000362	CcSEcCtD
L-Carnitine—Diarrhoea—Docetaxel—prostate cancer	4.96e-05	0.000361	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—prostate cancer	4.94e-05	0.00036	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—prostate cancer	4.94e-05	0.00036	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—prostate cancer	4.9e-05	0.000357	CcSEcCtD
L-Carnitine—Infection—Epirubicin—prostate cancer	4.86e-05	0.000354	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—prostate cancer	4.84e-05	0.000352	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—prostate cancer	4.8e-05	0.00035	CcSEcCtD
L-Carnitine—Diarrhoea—Capecitabine—prostate cancer	4.8e-05	0.00035	CcSEcCtD
L-Carnitine—Dizziness—Docetaxel—prostate cancer	4.79e-05	0.000349	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—prostate cancer	4.79e-05	0.000348	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—prostate cancer	4.77e-05	0.000347	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—prostate cancer	4.72e-05	0.000344	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—prostate cancer	4.72e-05	0.000344	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—prostate cancer	4.7e-05	0.000342	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—prostate cancer	4.66e-05	0.000339	CcSEcCtD
L-Carnitine—Dizziness—Capecitabine—prostate cancer	4.64e-05	0.000338	CcSEcCtD
L-Carnitine—Vomiting—Docetaxel—prostate cancer	4.61e-05	0.000336	CcSEcCtD
L-Carnitine—Hypersensitivity—Prednisone—prostate cancer	4.61e-05	0.000335	CcSEcCtD
L-Carnitine—Rash—Docetaxel—prostate cancer	4.57e-05	0.000333	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—prostate cancer	4.57e-05	0.000333	CcSEcCtD
L-Carnitine—Dermatitis—Docetaxel—prostate cancer	4.57e-05	0.000332	CcSEcCtD
L-Carnitine—Headache—Docetaxel—prostate cancer	4.54e-05	0.000331	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—prostate cancer	4.49e-05	0.000327	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—prostate cancer	4.49e-05	0.000327	CcSEcCtD
L-Carnitine—Vomiting—Capecitabine—prostate cancer	4.46e-05	0.000325	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.45e-05	0.000324	CcSEcCtD
L-Carnitine—Rash—Capecitabine—prostate cancer	4.43e-05	0.000322	CcSEcCtD
L-Carnitine—Pruritus—Prednisone—prostate cancer	4.42e-05	0.000322	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—prostate cancer	4.42e-05	0.000322	CcSEcCtD
L-Carnitine—Dermatitis—Capecitabine—prostate cancer	4.42e-05	0.000322	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—prostate cancer	4.42e-05	0.000321	CcSEcCtD
L-Carnitine—Headache—Capecitabine—prostate cancer	4.4e-05	0.00032	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—prostate cancer	4.39e-05	0.00032	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—prostate cancer	4.36e-05	0.000317	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—prostate cancer	4.31e-05	0.000314	CcSEcCtD
L-Carnitine—Nausea—Docetaxel—prostate cancer	4.31e-05	0.000313	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—prostate cancer	4.3e-05	0.000313	CcSEcCtD
L-Carnitine—Diarrhoea—Prednisone—prostate cancer	4.28e-05	0.000311	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—prostate cancer	4.25e-05	0.000309	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—prostate cancer	4.23e-05	0.000308	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—prostate cancer	4.22e-05	0.000307	CcSEcCtD
L-Carnitine—Pain—Epirubicin—prostate cancer	4.18e-05	0.000304	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—prostate cancer	4.18e-05	0.000304	CcSEcCtD
L-Carnitine—Nausea—Capecitabine—prostate cancer	4.17e-05	0.000304	CcSEcCtD
L-Carnitine—Dizziness—Prednisone—prostate cancer	4.13e-05	0.000301	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.12e-05	0.0003	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—prostate cancer	4.09e-05	0.000298	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—prostate cancer	4.06e-05	0.000296	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—prostate cancer	4.03e-05	0.000294	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—prostate cancer	4e-05	0.000291	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—prostate cancer	3.98e-05	0.00029	CcSEcCtD
L-Carnitine—Vomiting—Prednisone—prostate cancer	3.98e-05	0.000289	CcSEcCtD
L-Carnitine—Rash—Prednisone—prostate cancer	3.94e-05	0.000287	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—prostate cancer	3.94e-05	0.000287	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—prostate cancer	3.93e-05	0.000286	CcSEcCtD
L-Carnitine—Headache—Prednisone—prostate cancer	3.92e-05	0.000285	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.91e-05	0.000284	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—prostate cancer	3.87e-05	0.000282	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—prostate cancer	3.87e-05	0.000282	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—prostate cancer	3.87e-05	0.000281	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—prostate cancer	3.87e-05	0.000281	CcSEcCtD
L-Carnitine—Nausea—Prednisone—prostate cancer	3.71e-05	0.00027	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.7e-05	0.000269	CcSEcCtD
L-Carnitine—Hypersensitivity—Epirubicin—prostate cancer	3.6e-05	0.000262	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—prostate cancer	3.58e-05	0.00026	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—prostate cancer	3.58e-05	0.00026	CcSEcCtD
L-Carnitine—Asthenia—Epirubicin—prostate cancer	3.51e-05	0.000255	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—prostate cancer	3.46e-05	0.000252	CcSEcCtD
L-Carnitine—Diarrhoea—Epirubicin—prostate cancer	3.35e-05	0.000244	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—prostate cancer	3.33e-05	0.000243	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—prostate cancer	3.25e-05	0.000236	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—prostate cancer	3.23e-05	0.000235	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—prostate cancer	3.2e-05	0.000233	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—prostate cancer	3.11e-05	0.000226	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—prostate cancer	3.1e-05	0.000225	CcSEcCtD
L-Carnitine—Rash—Epirubicin—prostate cancer	3.08e-05	0.000224	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—prostate cancer	3.08e-05	0.000224	CcSEcCtD
L-Carnitine—Headache—Epirubicin—prostate cancer	3.06e-05	0.000223	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—prostate cancer	2.99e-05	0.000218	CcSEcCtD
L-Carnitine—Nausea—Epirubicin—prostate cancer	2.9e-05	0.000211	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—prostate cancer	2.88e-05	0.000209	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—prostate cancer	2.85e-05	0.000208	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—prostate cancer	2.85e-05	0.000207	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—prostate cancer	2.83e-05	0.000206	CcSEcCtD
L-Carnitine—Nausea—Doxorubicin—prostate cancer	2.69e-05	0.000196	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—SLC5A5—prostate cancer	1.24e-05	9.15e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HSD3B2—prostate cancer	1.23e-05	9.08e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTO1—prostate cancer	1.23e-05	9.08e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NAT2—prostate cancer	1.23e-05	9.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.22e-05	9e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.22e-05	8.97e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2E1—prostate cancer	1.21e-05	8.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.2e-05	8.88e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NQO1—prostate cancer	1.2e-05	8.84e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—prostate cancer	1.19e-05	8.77e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.19e-05	8.76e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DEGS1—prostate cancer	1.18e-05	8.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP3A43—prostate cancer	1.18e-05	8.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAT1—prostate cancer	1.18e-05	8.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AMACR—prostate cancer	1.18e-05	8.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SRD5A2—prostate cancer	1.18e-05	8.72e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLCB2—prostate cancer	1.18e-05	8.71e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TH—prostate cancer	1.18e-05	8.71e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LRP2—prostate cancer	1.18e-05	8.71e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2C18—prostate cancer	1.18e-05	8.71e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.17e-05	8.65e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—prostate cancer	1.17e-05	8.63e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—prostate cancer	1.17e-05	8.63e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—prostate cancer	1.17e-05	8.63e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP3A4—prostate cancer	1.17e-05	8.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.16e-05	8.58e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.16e-05	8.57e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—prostate cancer	1.16e-05	8.55e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—prostate cancer	1.16e-05	8.55e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—P4HB—prostate cancer	1.16e-05	8.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.16e-05	8.53e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1B1—prostate cancer	1.15e-05	8.47e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARA—prostate cancer	1.15e-05	8.47e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PPARA—prostate cancer	1.15e-05	8.47e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—EP300—prostate cancer	1.13e-05	8.36e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RXRA—prostate cancer	1.13e-05	8.33e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD17B1—prostate cancer	1.13e-05	8.32e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.13e-05	8.32e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC22A1—prostate cancer	1.13e-05	8.31e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GGT1—prostate cancer	1.11e-05	8.2e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SULT2A1—prostate cancer	1.1e-05	8.1e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOA1—prostate cancer	1.1e-05	8.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.08e-05	8e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MED12—prostate cancer	1.08e-05	7.96e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP19A1—prostate cancer	1.08e-05	7.96e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAV1—prostate cancer	1.08e-05	7.96e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.08e-05	7.96e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.07e-05	7.92e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNG5—prostate cancer	1.07e-05	7.9e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.07e-05	7.88e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—RXRA—prostate cancer	1.04e-05	7.69e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA3—prostate cancer	1.03e-05	7.61e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.03e-05	7.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.03e-05	7.57e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	1.02e-05	7.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.02e-05	7.51e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.01e-05	7.48e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—prostate cancer	1.01e-05	7.45e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—prostate cancer	1.01e-05	7.45e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPGD—prostate cancer	1.01e-05	7.42e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—B4GALT4—prostate cancer	1.01e-05	7.42e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—COMT—prostate cancer	1e-05	7.4e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—prostate cancer	9.99e-06	7.37e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HPGDS—prostate cancer	9.84e-06	7.26e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—prostate cancer	9.83e-06	7.25e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ITPR1—prostate cancer	9.83e-06	7.25e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2C19—prostate cancer	9.78e-06	7.22e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.67e-06	7.14e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.66e-06	7.13e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—EP300—prostate cancer	9.63e-06	7.11e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—EP300—prostate cancer	9.63e-06	7.11e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ACHE—prostate cancer	9.54e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—prostate cancer	9.54e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TNFRSF21—prostate cancer	9.45e-06	6.97e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2A6—prostate cancer	9.43e-06	6.96e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—INS—prostate cancer	9.31e-06	6.87e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMS—prostate cancer	9.28e-06	6.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.23e-06	6.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTAP—prostate cancer	9.19e-06	6.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP7B1—prostate cancer	9.19e-06	6.78e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—prostate cancer	9.18e-06	6.77e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKR1C3—prostate cancer	9.18e-06	6.77e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PRKACB—prostate cancer	9.13e-06	6.74e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CREBBP—prostate cancer	9.11e-06	6.73e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.11e-06	6.72e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP17A1—prostate cancer	9.03e-06	6.67e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—LPL—prostate cancer	9.01e-06	6.65e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	8.99e-06	6.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SULT1E1—prostate cancer	8.96e-06	6.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SRD5A1—prostate cancer	8.96e-06	6.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	8.7e-06	6.42e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—prostate cancer	8.7e-06	6.42e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—prostate cancer	8.64e-06	6.38e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ERCC2—prostate cancer	8.63e-06	6.37e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	8.63e-06	6.36e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA2—prostate cancer	8.61e-06	6.35e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	8.57e-06	6.33e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD17B3—prostate cancer	8.55e-06	6.31e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACSL4—prostate cancer	8.55e-06	6.31e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	8.45e-06	6.23e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—prostate cancer	8.38e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A5—prostate cancer	8.21e-06	6.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ARG2—prostate cancer	8.2e-06	6.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UMPS—prostate cancer	8.2e-06	6.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PHGDH—prostate cancer	8.2e-06	6.05e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—prostate cancer	8.16e-06	6.02e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	8.15e-06	6.02e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.15e-06	6.02e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—prostate cancer	8.11e-06	5.98e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LDHB—prostate cancer	8.04e-06	5.93e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2E1—prostate cancer	8.02e-06	5.92e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARA—prostate cancer	7.96e-06	5.87e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NQO1—prostate cancer	7.93e-06	5.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP3A5—prostate cancer	7.89e-06	5.82e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TH—prostate cancer	7.82e-06	5.77e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	7.8e-06	5.76e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RXRA—prostate cancer	7.75e-06	5.72e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP3A4—prostate cancer	7.73e-06	5.71e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UCP3—prostate cancer	7.62e-06	5.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PDHA1—prostate cancer	7.62e-06	5.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TCN2—prostate cancer	7.62e-06	5.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA3—prostate cancer	7.62e-06	5.62e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1B1—prostate cancer	7.6e-06	5.61e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—prostate cancer	7.53e-06	5.56e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAV1—prostate cancer	7.48e-06	5.52e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—prostate cancer	7.46e-06	5.51e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GGT1—prostate cancer	7.36e-06	5.43e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD3B1—prostate cancer	7.27e-06	5.36e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC22A3—prostate cancer	7.27e-06	5.36e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA1—prostate cancer	7.25e-06	5.35e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP19A1—prostate cancer	7.15e-06	5.28e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.15e-06	5.27e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—prostate cancer	7.13e-06	5.26e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—prostate cancer	7.13e-06	5.26e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.05e-06	5.2e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TBXAS1—prostate cancer	6.97e-06	5.14e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA4—prostate cancer	6.97e-06	5.14e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—RXRA—prostate cancer	6.9e-06	5.09e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.85e-06	5.05e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—prostate cancer	6.85e-06	5.05e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—prostate cancer	6.81e-06	5.03e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.81e-06	5.03e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA2—prostate cancer	6.79e-06	5.01e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SULT1A1—prostate cancer	6.71e-06	4.95e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCG5—prostate cancer	6.71e-06	4.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—COMT—prostate cancer	6.65e-06	4.9e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—prostate cancer	6.62e-06	4.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA1—prostate cancer	6.55e-06	4.83e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—prostate cancer	6.51e-06	4.8e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ITPR1—prostate cancer	6.51e-06	4.8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTO1—prostate cancer	6.48e-06	4.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD3B2—prostate cancer	6.48e-06	4.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAT2—prostate cancer	6.48e-06	4.78e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—INS—prostate cancer	6.45e-06	4.76e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CREBBP—prostate cancer	6.32e-06	4.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.23e-06	4.6e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LRP2—prostate cancer	6.21e-06	4.58e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2C18—prostate cancer	6.21e-06	4.58e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLCB2—prostate cancer	6.21e-06	4.58e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—EP300—prostate cancer	6.21e-06	4.58e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.19e-06	4.57e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMS—prostate cancer	6.15e-06	4.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—P4HB—prostate cancer	6.09e-06	4.49e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—prostate cancer	6.08e-06	4.49e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—prostate cancer	5.99e-06	4.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LPL—prostate cancer	5.97e-06	4.4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC22A1—prostate cancer	5.92e-06	4.37e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PPARA—prostate cancer	5.92e-06	4.37e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.86e-06	4.32e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—prostate cancer	5.82e-06	4.3e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—prostate cancer	5.82e-06	4.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SULT2A1—prostate cancer	5.77e-06	4.26e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—prostate cancer	5.76e-06	4.25e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ERCC2—prostate cancer	5.72e-06	4.22e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MED12—prostate cancer	5.68e-06	4.19e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—prostate cancer	5.66e-06	4.17e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNG5—prostate cancer	5.64e-06	4.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA3—prostate cancer	5.43e-06	4.01e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—prostate cancer	5.37e-06	3.96e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.33e-06	3.94e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARA—prostate cancer	5.27e-06	3.89e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—prostate cancer	5.22e-06	3.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPGDS—prostate cancer	5.18e-06	3.82e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—prostate cancer	5.17e-06	3.82e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2C19—prostate cancer	5.15e-06	3.8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACHE—prostate cancer	5.02e-06	3.71e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—prostate cancer	5.02e-06	3.71e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2A6—prostate cancer	4.97e-06	3.66e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAV1—prostate cancer	4.96e-06	3.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.95e-06	3.65e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKR1C3—prostate cancer	4.83e-06	3.56e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PRKACB—prostate cancer	4.8e-06	3.55e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP17A1—prostate cancer	4.75e-06	3.51e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.7e-06	3.47e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.69e-06	3.46e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—prostate cancer	4.59e-06	3.39e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA2—prostate cancer	4.53e-06	3.34e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—prostate cancer	4.51e-06	3.33e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—prostate cancer	4.51e-06	3.33e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A5—prostate cancer	4.32e-06	3.19e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—EP300—prostate cancer	4.3e-06	3.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—INS—prostate cancer	4.27e-06	3.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2E1—prostate cancer	4.22e-06	3.12e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CREBBP—prostate cancer	4.19e-06	3.09e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NQO1—prostate cancer	4.17e-06	3.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TH—prostate cancer	4.11e-06	3.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.09e-06	3.02e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP3A4—prostate cancer	4.07e-06	3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.05e-06	2.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1B1—prostate cancer	4e-06	2.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—prostate cancer	3.97e-06	2.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GGT1—prostate cancer	3.88e-06	2.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA1—prostate cancer	3.82e-06	2.82e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP19A1—prostate cancer	3.76e-06	2.78e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—prostate cancer	3.75e-06	2.77e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—prostate cancer	3.75e-06	2.77e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—RXRA—prostate cancer	3.63e-06	2.68e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.53e-06	2.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COMT—prostate cancer	3.5e-06	2.58e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—prostate cancer	3.48e-06	2.57e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—prostate cancer	3.46e-06	2.55e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—prostate cancer	3.43e-06	2.53e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ITPR1—prostate cancer	3.43e-06	2.53e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.37e-06	2.49e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMS—prostate cancer	3.24e-06	2.39e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—prostate cancer	3.2e-06	2.36e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—prostate cancer	3.18e-06	2.35e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LPL—prostate cancer	3.14e-06	2.32e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—prostate cancer	3.03e-06	2.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ERCC2—prostate cancer	3.01e-06	2.22e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—prostate cancer	2.99e-06	2.21e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EP300—prostate cancer	2.85e-06	2.1e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—prostate cancer	2.83e-06	2.09e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARA—prostate cancer	2.77e-06	2.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAV1—prostate cancer	2.61e-06	1.92e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—prostate cancer	2.6e-06	1.92e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.49e-06	1.84e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	2.38e-06	1.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—INS—prostate cancer	2.25e-06	1.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CREBBP—prostate cancer	2.2e-06	1.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—prostate cancer	2.11e-06	1.56e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	2.09e-06	1.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—prostate cancer	1.97e-06	1.46e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	1.82e-06	1.34e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—prostate cancer	1.8e-06	1.33e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—prostate cancer	1.72e-06	1.27e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—prostate cancer	1.57e-06	1.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EP300—prostate cancer	1.5e-06	1.11e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.11e-06	8.19e-06	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—prostate cancer	9.07e-07	6.69e-06	CbGpPWpGaD
